TABLE 1. GLOBAL CANCER GENE THERAPY MARKET, BY THERAPY, 2016-2023 ($MILLION)
TABLE 2. CANCER GENE THERAPY MARKET FOR GENE INDUCED IMMUNOTHERAPY, BY REGION, 2016-2023 ($MILLION)
TABLE 3. CANCER GENE THERAPY MARKET FOR ONCOLYTIC VIROTHERAPY, BY REGION, 2016-2023 ($MILLION)
TABLE 4. CANCER GENE THERAPY MARKET FOR GENE TRANSFER, BY REGION, 2016-2023 ($MILLION)
TABLE 5. CANCER GENE THERAPY MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 6. NORTH AMERICA CANCER GENE THERAPY MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 7. NORTH AMERICA CANCER GENE THERAPY MARKET, BY THERAPY, 2016-2023 ($MILLION)
TABLE 8. EUROPE CANCER GENE THERAPY MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 9. EUROPE CANCER GENE THERAPY MARKET, BY THERAPY, 2016-2023 ($MILLION)
TABLE 10. ASIA-PACIFIC CANCER GENE THERAPY MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 11. ASIA-PACIFIC CANCER GENE THERAPY MARKET, BY THERAPY, 2016-2023 ($MILLION)
TABLE 12. LAMEA CANCER GENE THERAPY MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 13. LAMEA CANCER GENE THERAPY MARKET, BY THERAPY, 2016-2023 ($MILLION)
TABLE 14. ADAPTIMMUNE: COMPANY SNAPSHOT
TABLE 15. ADAPTIMMUNE: OPERATING SEGMENTS
TABLE 16. GLAXOSMITHKLINE: COMPANY SNAPSHOT
TABLE 17. GLAXOSMITHKLINE: OPERATING SEGMENTS
TABLE 18. BLUEBIRD: COMPANY SNAPSHOT
TABLE 19. BLUEBIRD: OPERATING SEGMENTS
TABLE 20. MERCK: COMPANY SNAPSHOT
TABLE 21. MERCK: OPERATING SEGMENTS
TABLE 22. CELGENE: COMPANY SNAPSHOT
TABLE 23. CELGENE: OPERATING SEGMENTS
TABLE 24. SHANGHAI SUNWAY BIOTECH: COMPANY SNAPSHOT
TABLE 25. SHANGHAI SUNWAY BIOTECH: OPERATING SEGMENTS
TABLE 26. BIOCANCELL: COMPANY SNAPSHOT
TABLE 27. BIOCANCELL: OPERATING SEGMENTS
TABLE 28. SHENZHEN SIBIONO GENETECH: COMPANY SNAPSHOT
TABLE 29. SHENZHEN SIBIONO GENETECH: OPERATING SEGMENTS
TABLE 30. SYNERGENE THERAPEUTICS: COMPANY SNAPSHOT
TABLE 31. SYNERGENE THERAPEUTICS: OPERATING SEGMENTS
TABLE 32. ONCOGENEX PHARMACEUTICALS: COMPANY SNAPSHOT
TABLE 33. ONCOGENEX PHARMACEUTICALS: OPERATING SEGMENTS

LIST OF FIGURE

FIGURE 1. SEGMENTATION OF GLOBAL CANCER GENE THERAPY MARKET
FIGURE 2. TOP INVESTMENT POCKETS IN GLOBAL CANCER GENE THERAPY MARKET 2016
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2014-2016)
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE (2014-2016)
FIGURE 5. TOP WINNING STRATEGIES: NATURE AND COMPANY (2014-2016)
FIGURE 6. BARGAINING POWER OF BUYERS
FIGURE 7. BARGAINING POWER OF SUPPLIERS
FIGURE 8. THREAT OF NEW ENTRANTS
FIGURE 9. THREAT OF SUBSTITUTION
FIGURE 10. COMPETITIVE RIVALRY
FIGURE 11. RESTRAINTS AND DRIVERS: GLOBAL CANCER GENE THERAPY MARKET
FIGURE 12. GLOBAL CANCER GENE THERAPY MARKET: SEGMENTATION BY TYPE
FIGURE 13. U.S. CANCER GENE THERAPY MARKET, 2016-2023 ($MILLION)
FIGURE 14. MEXICO CANCER GENE THERAPY MARKET, 2016-2023 ($MILLION)
FIGURE 15. CANADA CANCER GENE THERAPY MARKET, 2016-2023 ($MILLION)
FIGURE 16. UK CANCER GENE THERAPY MARKET, 2016-2023 ($MILLION)
FIGURE 17. FRANCE CANCER GENE THERAPY MARKET, 2016-2023 ($MILLION)
FIGURE 18. GERMANY CANCER GENE THERAPY MARKET, 2016-2023 ($MILLION)
FIGURE 19. REST OF EUROPE CANCER GENE THERAPY MARKET, 2016-2023 ($MILLION)
FIGURE 20. INDIA CANCER GENE THERAPY MARKET, 2016-2023 ($MILLION)
FIGURE 21. JAPAN CANCER GENE THERAPY MARKET, 2016-2023 ($MILLION)
FIGURE 22. CHINA CANCER GENE THERAPY MARKET, 2016-2023 ($MILLION)
FIGURE 23. REST OF ASIA-PACIFIC CANCER GENE THERAPY MARKET, 2016-2023 ($MILLION)
FIGURE 24. BRAZIL CANCER GENE THERAPY MARKET, 2016-2023 ($MILLION)
FIGURE 25. SOUTH AFRICA CANCER GENE THERAPY MARKET, 2016-2023 ($MILLION)
FIGURE 26. SAUDI ARABIA CANCER GENE THERAPY MARKET, 2016-2023 ($MILLION)
FIGURE 27. REST OF LAMEA CANCER GENE THERAPY MARKET, 2016-2023 ($MILLION)